BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li SB, Giardino WJ, de Lecea L. Hypocretins and Arousal. Curr Top Behav Neurosci 2017;33:93-104. [PMID: 28012091 DOI: 10.1007/7854_2016_58] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Matzeu A, Kallupi M, George O, Schweitzer P, Martin-Fardon R. Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence. Neuropsychopharmacology 2018;43:1010-20. [PMID: 29052613 DOI: 10.1038/npp.2017.250] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
2 Boss C, Roch C. Orexin research: patent news from 2016. Expert Opinion on Therapeutic Patents 2017;27:1123-33. [DOI: 10.1080/13543776.2017.1344221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
3 Mohammadkhani A, Fragale JE, Pantazis CB, Bowrey HE, James MH, Aston-Jones G. Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil. J Neurosci 2019;39:9831-40. [PMID: 31641055 DOI: 10.1523/JNEUROSCI.0255-19.2019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
4 Macías-triana L, Romero-cordero K, Tatum-kuri A, Vera-barrón A, Millán-aldaco D, Arankowsky-sandoval G, Piomelli D, Murillo-rodríguez E. Exposure to the cannabinoid agonist WIN 55, 212–2 in adolescent rats causes sleep alterations that persist until adulthood. European Journal of Pharmacology 2020;874:172911. [DOI: 10.1016/j.ejphar.2020.172911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Leung LC, Mourrain P. Sleep: Short Sleepers Should Keep Count of Their Hypocretin Neurons. Curr Biol 2018;28:R558-60. [PMID: 29738730 DOI: 10.1016/j.cub.2018.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Rinne MK, Leino TO, Turku A, Turunen PM, Steynen Y, Xhaard H, Wallén EA, Kukkonen JP. Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26. European Journal of Pharmacology 2018;837:137-44. [DOI: 10.1016/j.ejphar.2018.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
7 Li SB, Nevárez N, Giardino WJ, de Lecea L. Optical probing of orexin/hypocretin receptor antagonists. Sleep 2018;41. [PMID: 30060151 DOI: 10.1093/sleep/zsy141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kandel H, Pfaff DW. Arousal. Stress: Physiology, Biochemistry, and Pathology. Elsevier; 2019. pp. 1-18. [DOI: 10.1016/b978-0-12-813146-6.00001-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 James MH, Fragale JE, O'Connor SL, Zimmer BA, Aston-Jones G. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse. Neuropharmacology 2021;183:108359. [PMID: 33091458 DOI: 10.1016/j.neuropharm.2020.108359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Giardino WJ, Eban-Rothschild A, Christoffel DJ, Li SB, Malenka RC, de Lecea L. Parallel circuits from the bed nuclei of stria terminalis to the lateral hypothalamus drive opposing emotional states. Nat Neurosci 2018;21:1084-95. [PMID: 30038273 DOI: 10.1038/s41593-018-0198-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 21.0] [Reference Citation Analysis]
11 Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Williams RH, Tsunematsu T, Thomas AM, Bogyo K, Yamanaka A, Kilduff TS. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy. J Neurosci 2019;39:9435-52. [PMID: 31628177 DOI: 10.1523/JNEUROSCI.0311-19.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
13 Cui S, Huang Y, Cui X, Zhao H, Hu X, Liu Y, Qin Y, Kurban N, Zhang Y. A common neuronal mechanism of hypertension and sleep disturbances in spontaneously hypertensive rats: Role of orexinergic neurons. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2020;100:109902. [DOI: 10.1016/j.pnpbp.2020.109902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sheng Q, Xue Y, Wang Y, Chen AQ, Liu C, Liu YH, Chu HY, Chen L. The Subthalamic Neurons are Activated by Both Orexin-A and Orexin-B. Neuroscience 2018;369:97-108. [PMID: 29138106 DOI: 10.1016/j.neuroscience.2017.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
15 Giardino WJ, Pomrenze MB. Extended Amygdala Neuropeptide Circuitry of Emotional Arousal: Waking Up on the Wrong Side of the Bed Nuclei of Stria Terminalis. Front Behav Neurosci 2021;15:613025. [PMID: 33633549 DOI: 10.3389/fnbeh.2021.613025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]